StockData
AC Immune SA logo

AC Immune SA (ACIU) stock

ACIUNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 13, 2026Score 3/30
$2.11+0.02 (+0.96%)

Close on Nov 17, 2026Market cap $214.68MP/E –Yield –

AC Immune price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

AC Immune's price to sales ratio was 52.2× on Nov 11, 2026, against 8.8× a year earlier. Over the last 5 years it ranged from 2.9× to 89.2×, with a median of 25.5×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202652.2×+43.1
2025Dec 31, 20259.1×−4.9
2024Dec 31, 202414.0×−75.2
2023Dec 29, 202389.2×+70.1
2022Jan 31, 202219.2×−1.9
2021Dec 31, 202121.1×+18.2
2020Dec 31, 20202.9×−70.8
2019Dec 31, 201973.8×+48.9
2018Dec 31, 201824.9×−2.0
2017Dec 29, 201726.9×+11.4
2016Dec 30, 201615.5×–

More AC Immune figures

See a number that looks wrong?